ExxonMobil's Nigerian asset sale nears approval    Argentina's GDP to contract by 3.3% in '24, grow 2.7% in '25: OECD    Chubb prepares $350M payout for state of Maryland over bridge collapse    Turkey's GDP growth to decelerate in next 2 years – OECD    EU pledges €7.4bn to back Egypt's green economy initiatives    Yen surges against dollar on intervention rumours    $17.7bn drop in banking sector's net foreign assets deficit during March 2024: CBE    Norway's Scatec explores 5 new renewable energy projects in Egypt    Egypt, France emphasize ceasefire in Gaza, two-state solution    Microsoft plans to build data centre in Thailand    Japanese Ambassador presents Certificate of Appreciation to renowned Opera singer Reda El-Wakil    WFP, EU collaborate to empower refugees, host communities in Egypt    Health Minister, Johnson & Johnson explore collaborative opportunities at Qatar Goals 2024    Egypt facilitates ceasefire talks between Hamas, Israel    Al-Sisi, Emir of Kuwait discuss bilateral ties, Gaza takes centre stage    AstraZeneca, Ministry of Health launch early detection and treatment campaign against liver cancer    Sweilam highlights Egypt's water needs, cooperation efforts during Baghdad Conference    AstraZeneca injects $50m in Egypt over four years    Egypt, AstraZeneca sign liver cancer MoU    Swiss freeze on Russian assets dwindles to $6.36b in '23    Amir Karara reflects on 'Beit Al-Rifai' success, aspires for future collaborations    Climate change risks 70% of global workforce – ILO    Prime Minister Madbouly reviews cooperation with South Sudan    Ramses II statue head returns to Egypt after repatriation from Switzerland    Egypt retains top spot in CFA's MENA Research Challenge    Egyptian public, private sectors off on Apr 25 marking Sinai Liberation    Debt swaps could unlock $100b for climate action    President Al-Sisi embarks on new term with pledge for prosperity, democratic evolution    Amal Al Ghad Magazine congratulates President Sisi on new office term    Egyptian, Japanese Judo communities celebrate new coach at Tokyo's Embassy in Cairo    Uppingham Cairo and Rafa Nadal Academy Unite to Elevate Sports Education in Egypt with the Introduction of the "Rafa Nadal Tennis Program"    Financial literacy becomes extremely important – EGX official    Euro area annual inflation up to 2.9% – Eurostat    BYD، Brazil's Sigma Lithium JV likely    UNESCO celebrates World Arabic Language Day    Motaz Azaiza mural in Manchester tribute to Palestinian journalists    Russia says it's in sync with US, China, Pakistan on Taliban    It's a bit frustrating to draw at home: Real Madrid keeper after Villarreal game    Shoukry reviews with Guterres Egypt's efforts to achieve SDGs, promote human rights    Sudan says countries must cooperate on vaccines    Johnson & Johnson: Second shot boosts antibodies and protection against COVID-19    Egypt to tax bloggers, YouTubers    Egypt's FM asserts importance of stability in Libya, holding elections as scheduled    We mustn't lose touch: Muller after Bayern win in Bundesliga    Egypt records 36 new deaths from Covid-19, highest since mid June    Egypt sells $3 bln US-dollar dominated eurobonds    Gamal Hanafy's ceramic exhibition at Gezira Arts Centre is a must go    Italian Institute Director Davide Scalmani presents activities of the Cairo Institute for ITALIANA.IT platform    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.



Will the US ever have a national COVID-19 testing strategy?
Published in Ahram Online on 06 - 12 - 2020

As the coronavirus epidemic worsens, U.S. health experts hope Joe Biden's administration will put in place something Donald Trump's has not _ a comprehensive national testing strategy.
Such a strategy, they say, could systematically check more people for infections and spot surges before they take off. The health experts say it would be an improvement from the current practice, which has professional athletes and students at elite universities getting routine tests while many other Americans stand in line for hours _ if they get tested at all.
``We have had no strategy for this virus. Our strategy has been no strategy,'' said Dr. Michael Mina, a Harvard University researcher focused on use of testing to track disease.
Some experts say the lack of such a system is one reason for the current national explosion in cases, hospitalizations and deaths.
``If we'd had a more robust approach and testing was scaled up as one of the tools, I think much of this third surge would would have been avoidable,`` said Dr. Grant Colfax, director of the San Francisco Department of Public Health.
There are differing opinions on what such a strategy should look like, but many experts say rapid and at-home tests should be used so Americans can check themselves and stay away from others if they test positive.
The president-elect has endorsed that strategy, called for making testing free for all Americans, and said government experts at the Centers for Disease Control and Prevention and other agencies should be empowered to coordinate the entire effort.
``The reality is we're not testing enough today,`` Dr. Marcella Nunez-Smith, co-chair of Biden's coronavirus advisory board, told The Associated Press this week.
His transition team so far has not gone into further detail.
Testing was one of the first _ and most enduring _ stumbles in the federal government's response to the coronavirus epidemic that hit the nation early this year.
In February, the CDC distributed test kits to public health laboratories that initially were faulty. U.S. officials worked with companies to expand testing, but shortages of chemicals, materials and protective equipment meant fewer tests were available than what experts said was necessary.
Worse, some experts say, states and cities competed against each other to buy limited testing services and materials, and with little guidance or training on how to best use the tests.
In April, President Donald Trump declared governors were responsible for testing. Amid complaints about shortages and delays, the federal government began sourcing and shipping key testing supplies to states, beginning with swabs.
In the latest phase, Trump officials are sending more than 100 million rapid, point-of-care tests to states. The government said the first shipments went out in early October.
Such tests are considered key to slowing spread, but states have distributed them differently. For example, Alaska is sending tests to oil drilling sites, Colorado to local public health agencies for testing homeless populations, and Mississippi to veterans' homes.
There's also no federal standard for reporting test data. Some states report the number of tests administered, while others tally the number of people tested. Some have counted types of tests that others don't, which can skew results because some tests are better at diagnosing active infections than others.
Administration officials say they are proud of the current state of testing. Last month, Vice President Mike Pence celebrated that 170 million tests have been completed, and that an expanding array of tests are available.
But the focus should be less on numbers and more on action, said Dr. Ali Khan, dean of the University of Nebraska College of Public Health.
``It shouldn't be anybody who needs a test can get a test,`` Khan said. ``It should be anybody who has a positive test immediately gets isolated'' and the people they were in contact with checked and placed in quarantine.
He was echoed by Nunez-Smith, the Biden coronavirus adviser.
``Testing is only useful when we can act on the test,'' said Nunez-Smith, a Yale health equity researcher.
Trump himself has voiced a lack of enthusiasm for comprehensive testing. In a June tweet, the president called testing a double-edged sword that is good to have but ``makes us look bad.'' And Dr. Scott Atlas _ a top pandemic adviser to Trump before he resigned Monday _ argued against testing people who aren't experiencing symptoms.
But some regard such thinking as an attempt to spin a leadership failure into something else.
``The executive branch has seen test results - case counts - as a report card on its performance,'' said Carl Bergstrom, a University of Washington evolutionary biologist who studies emerging infectious diseases.
The nation may be weeks away from coronavirus vaccines becoming available, but that won't erase the need for testing, said the Rockefeller Foundation's Eileen O'Connor.
``We're not going to get everybody vaccinated right away. And we still don't know how long that immunity will last,'' she said. So testing will still be needed to monitor where the infection is active and to see if infections are occurring in vaccinated people.
What should be done moving forward?
In July, the Rockefeller Foundation called for making cheap tests widely available to better identify people who are infected and don't know it. That would involve developing and making cheap antigen tests, which provide quick results but are less reliable than genetic tests. Foundation officials hoped the government would push companies to manufacture tests the same way it has pushed vaccine makers to mass produce experimental vaccines.
Some Harvard researchers believe that testing half the population each week would be possible by mailing those tests to millions of U.S. households.
Participation would be voluntary, and positive results would have to be confirmed with genetic tests _ the home tests are not considered as sensitive as more established lab-based testing. Even so, it could dramatically expand the amount of infection monitoring going on across the nation, its proponents say.
During an appearance on NBC's ``Meet the Press,'' Dr. Anthony Fauci of the National Institutes of Health said Americans should have easy tests they can do in their own homes.
``We don't have that,'' he said. ``We should have that.''
Versions of such an approach have been tried in some places, including Slovakia and Minnesota. But some experts note there is little precedent for screening tens of millions of people with cheap, rapid tests_which would generate a significant portion of false results. It's also unclear whether people who test themselves at home will follow instructions to quarantine.
Nearly all experts agree that more data and coordination is needed.
``Having every state do its own thing without guidance from the federal level _ from CDC in particular _ I think has really hampered us,'' said Scott Becker, the chief executive of the Association of Public Health Laboratories. ``It is a federal response as much as it is a state response, but it's a shared responsibility. We need to work together.''


Clic here to read the story from its source.